# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-107021
Filing Date
2024-04-23
Accepted
2024-04-23 16:11:13
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d605265dars.pdf | ARS | 8545439
| Complete submission text file | 0001193125-24-107021.txt |  | 11772242

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38938 | Film No.: 24864925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)